Infarcted myocardium in pigs: MR imaging enhanced with slow- interstitial-diffusion gadolinium compound P760

Radiology

Volumn 212, Issue 2, 1999, Pages 467-473

  Kroft, Lucia J M ^a   Doornbos, Joost ^a   Van Der Geest, Rob J ^a   Benderbous, Soraya ^b   De Roos, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Laboratoire Guerbet   (France)

Author keywords

Contrast media, comparative studies; Contrast media, experimental studies; Gadolinium; Heart, experimental studies; Myocardium, infarction; Myocardium, MR

Indexed keywords

GADOLINIUM CHELATE; GADOTERATE MEGLUMINE; GADOTERIC ACID; P 760; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SWINE;

EID: 0032791177     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.212.2.r99au15467     Document Type: Article

References (17)

1. Nishimura T, Kobayashi H, Ohara Y, et al. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. AJR 1989; 153:715-720.
2. de Roos A, Van Rossum AC, Van der Wall EE, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989; 172:717-720.
3. Lombardi M, Jones RA, Westby J, et al. MRI for the evaluation of regional myocardial perfusion in an experimental animal model. JMRI1997; 7:987-995.
4. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995; 92:1902-1910.
5. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997; 204:373-384.
6. Meyer D, Rousseaux O, Schaefer M, Simonot C; Laboratoire Guerbet France, assignee. P760. International patent WO.97/01359. January 16, 1997.
7. Port M, Meyer D, Bonnemain B, Corot C. MRI contrast agents characterized by new pharmacokinetic properties. MAGMA (in press).
8. deGreeve PCM, deLeeuw WA. Wettelijeke aspecten van dierproeven. In: Van Zuthphen LFM, Baumans V, Beynen AC, eds. Proefdieren en dierproeven. 2nd ed. Utrecht, the Netherlands: Wetenschappelijke Uitgeverij Bunge, 1995; 10-19.
9. Feldman S, Glagov S, Wissler RW, Hughes RH. Postmortem delineation of infarcted myocardium. Arch Pathol Lab Med 1976; 100:55-58.
10. Holman EH, Vliegen HW, van der Geest RJ, et al. Quantitative analysis of regional left ventricular function after myocardial infarction in the pig assessed with cine magnetic resonance imaging. Magn Reson Med 1995; 34:161-169.
11. Keijer JT, Van Rossum AC, Van Eenige MJ, et al. Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J 1995; 130:893-901.
12. van der Geest RJ, Buller VGM, Jansen E, et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short axis MR images. J Comput Assist Tomogr 1997; 21:756-765.
13. Burstein D, Taratuta E, Manning WJ. Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med 1991; 20:299-305.
14. Wilke N, Kroll K, Merkle H, et al. Regional myocardial blood volume and flow: first-pass MR imaging with polylysine-Gd-DTPA. JMRI 1995; 5:227-237.
15. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. JMRI 1994; 4:301-307.
16. Parmelee DJ, Walovitch RC, Quellet HS, Randall B, Lauffer B. Preclinical evaluations of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997; 32:741-747.
17. Eichenberger AC, Shuiki E, Kochli VD, Amann FW, McKinnon GC, von Schulthess GK. Ischemic heart disease: assessment with gadolinium-enhanced ultra-fast MR imaging and dipyridamole stress. JMRI 1994; 4:425-431.